Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
|
|
Ambrx Biopharma Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2023 |
4
| O'Connor Daniel J. (President and CEO) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 1,216,500 options to buy
@ $0 |
|
| 07/07/2023 |
4
| Nelson Sonja (CFO) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 389,000 options to buy
@ $0 |
|
| 07/07/2023 |
4
| Aromando Andrew (COO) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 389,000 options to buy
@ $0 |
|
| 06/28/2023 |
4
| Darwin Global Management, Ltd. (10% Owner) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Bought 5,384,063 options to buy
@ $0 |
|
| 06/09/2023 |
4
| Glover Stephen C. (Director) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 85,000 shares
@ $0
Granted 40,000 options to buy
@ $0
Granted 17,500 options to buy
@ $0 |
|
| 06/09/2023 |
4
| Chang Xiaowei (Director) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 85,000 options to buy
@ $0
Granted 125,000 options to buy
@ $0 |
|
| 06/09/2023 |
4
| Loesberg Janet (Director) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 85,000 shares
@ $0 |
|
| 06/09/2023 |
4
| MAIER PAUL V (Director) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 85,000 shares
@ $0 |
|
| 06/09/2023 |
4
| Hermans Kate (Director) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 85,000 shares
@ $0 |
|
| 05/26/2023 |
4
| Glover Stephen C. (Director) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 210,000 options to buy
@ $0 |
|
| 05/05/2023 |
4
| Aromando Andrew (COO) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 2,600,000 options to buy
@ $0 |
|
| 04/28/2023 |
4
| Nelson Sonja (Chief Fin. & Operating Officer) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 1,000,000 shares
@ $0 |
|
| 04/28/2023 |
4
| O'Connor Daniel J. (President and CEO) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 2,750,000 shares
@ $0 |
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2023 |
4
| Cormorant Asset Management, LP (10% Owner) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Bought 250,000 shares
@ $9.9531, valued at
$2.5M
Bought 250,000 shares
@ $10.5955, valued at
$2.6M
Bought 500,000 shares
@ $10.1485, valued at
$5.1M
|
|
| 03/08/2023 |
4
| Darwin Global Management, Ltd. (10% Owner) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Bought 65,127 options to buy
@ $0
Bought 39,957 options to buy
@ $0
Bought 3,615,000 options to buy
@ $0 |
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|